ACADIA Pharmaceuticals, Inc. (ACAD)
22.61
+0.52
(+2.35%)
USD |
NASDAQ |
Apr 08, 13:00
ACADIA Pharmaceuticals Cash from Investing (TTM) : -302.56M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Insmed, Inc. | -64.58M |
| Madrigal Pharmaceuticals, Inc. | 32.32M |
| Merck & Co., Inc. | -13.74B |
| Axsome Therapeutics, Inc. | -0.48M |
| Marker Therapeutics, Inc. | 0.00 |